ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/23/2023
Back to search
Official data from USPTO
XANGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
11/01/2025
Trademark type
Word
Nice classes
5
Filing date
01/17/2020
Registration date
09/21/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/21/2021
Last transaction
11/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2020-03-00
First use in commerce
2020-03-00
Drawing code
4
Owner type
16
Owner location
NASHVILLE, TN
Examiner
BUSH,KAREN K
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
HARROW IP, LLC
EYEVANCE PHARMACEUTICALS LLC
EYEVANCE PHARMACEUTICALS LLC
Representatives
Laila S. Wolfgram Polsinelli PC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Irrigating solutions for eye use; ocular pharmaceuticals; ophthalmic and ophthalmological preparations; pharmaceutical products for ophthalmological use; solutions for lubrication and rewetting the eyes; eye drops; solutions for ocular hydration; solutions for reducing ocular inflammation and pain associated with ocular surgery and other pathologies; pharmaceutical preparations for ocular or intraocular surgery; solutions for reducing symptoms associated with conjunctivitis; pharmaceutical preparations for the prevention and treatment of eye disordersdiseases and conditions; solutions and preparations for treating pathologies of the eyelids and eyelid margins; pharmaceutical preparationsa topical preparation for the treatment of ocular disorders prescribed by ophthalmologistseye surgeonsoptometrists
Publications
History of USPTO decisions and trademark events.
35 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/09/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/08/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/08/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/21/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/18/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/17/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/07/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/07/2021
IUAF
USE AMENDMENT FILED
07/26/2021
EISU
TEAS STATEMENT OF USE RECEIVED
07/26/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/22/2021
EX2G
SOU EXTENSION 2 GRANTED
06/18/2021
EXT2
SOU EXTENSION 2 FILED
06/18/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/18/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/19/2021
EX1G
SOU EXTENSION 1 GRANTED
01/15/2021
EXT1
SOU EXTENSION 1 FILED
01/15/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/15/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/21/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/26/2020
PUBO
PUBLISHED FOR OPPOSITION
05/26/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/06/2020
ALIE
ASSIGNED TO LIE
04/20/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/09/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/09/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/09/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/09/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/09/2020
DOCK
ASSIGNED TO EXAMINER
04/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/23/2020
NWAP
NEW APPLICATION ENTERED
01/21/2020
Continuous trademark protection
Get notified about every new filing that threatens XANGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.